Type 1 Diabetes Mellitus.
Syed FZ.
Ann Intern Med. 2022 Mar;175(3):ITC33-ITC48. doi: 10.7326/AITC202203150. Epub 2022 Mar 8.
Diabetic ketoacidosis.
Calimag APP, Chlebek S, Lerma EV, Chaiban JT.
Dis Mon. 2023 Mar;69(3):101418. doi: 10.1016/j.disamonth.2022.101418. Epub 2022 May 14.
Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus.
Castellanos L, Tuffaha M, Koren D, Levitsky LL.
Paediatr Drugs. 2020 Aug;22(4):357-367. doi: 10.1007/s40272-020-00397-0.
Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
Fayfman M, Pasquel FJ, Umpierrez GE.
Med Clin North Am. 2017 May;101(3):587-606. doi: 10.1016/j.mcna.2016.12.011.
Diabetic ketoacidosis: update on management.
Evans K.
Clin Med (Lond). 2019 Sep;19(5):396-398. doi: 10.7861/clinmed.2019-0284.
SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis.
Umapathysivam MM, Morgan B, Inglis JM, Meyer E, Liew D, Thiruvenkatarajan V, Jesudason D.
JAMA Netw Open. 2024 Mar 4;7(3):e242744. doi: 10.1001/jamanetworkopen.2024.2744.
The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management.
Nyenwe EA, Kitabchi AE.
Metabolism. 2016 Apr;65(4):507-21. doi: 10.1016/j.metabol.2015.12.007. Epub 2015 Dec 19.
Defining and characterising diabetic ketoacidosis in adults.
Dhatariya KK.
Diabetes Res Clin Pract. 2019 Sep;155:107797. doi: 10.1016/j.diabres.2019.107797. Epub 2019 Jul 22.
Diabetic Ketoacidosis: Evaluation and Treatment.
Veauthier B, Levy-Grau B.
Am Fam Physician. 2024 Nov;110(5):476-486.
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB.
Diabetes Care. 2015 Sep;38(9):1687-93. doi: 10.2337/dc15-0843. Epub 2015 Jun 15.
